Search Within

Yan Feng

Formats
  1. Journal Article (4)
  2. Meeting Abstract (1)
  3. Research Letter (1)
Groups
  1. Sloan Kettering Institute Postdocs (6)
  2. Cell Biology Program Faculty (5)
  3. GSK Faculty (5)
  4. Sloan Kettering Institute Faculty (5)
  5. MSK Grad Students (4)
  6. Alumni (GSK) (1)

More Groups

People
  1. Xuejun Jiang (5)
  2. Alexander Minikes (2)
  3. Helen Kang (2)
  4. Changhwan Yoon (1)
  5. Deguang Liang (1)
  6. Helena Yu (1)

More People

Years
  1. 2023 (3)
  2. 2019 (1)
  3. 2015 (2)
Publications
  1. Autophagy (1)
  2. Cell (1)
  3. Journal of Clinical Oncology (1)
  4. Nature Communications (1)
  5. Oncogene (1)
  6. Protein & Cell (1)
Publishers
  1. Nature Publishing Group (2)
  2. American Society of Clinical Oncology (1)
  3. Cell Press (1)
  4. Higher Education Press (1)
  5. Taylor & Francis Group (1)

Results (6)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Autophagy inhibition signals through senescence to promote tumor suppression
    Journal Article

    Peng, N.; Kang, H. H.; Feng, Y.; Minikes, A. M.; Jiang, X.
    Autophagy (2023)

    Fulltext@MSK | Save
  • Ferroptosis surveillance independent of GPX4 and differentially regulated by sex hormones
    Journal Article

    Liang, D.; Feng, Y.; Zandkarimi, F.; Wang, H.; Zhang, Z.; Kim, J.; Cai, Y.; Gu, W.; Stockwell, B. R.; Jiang, X.
    Cell (2023)

    Fulltext@MSK | Save
  • E-cadherin is a biomarker for ferroptosis sensitivity in diffuse gastric cancer
    Journal Article

    Minikes, A. M.; Song, Y.; Feng, Y.; Yoon, C.; Yoon, S. S.; Jiang, X.
    Oncogene (2023)

    Fulltext@MSK | Save
  • Unc-51-like kinase (ULK) complex-independent autophagy induced by hypoxia
    Research Letter

    Feng, Y.; Kang, H. H.; Wong, P. M.; Gao, M.; Wang, P.; Jiang, X.
    Protein & Cell (2019)

    Fulltext@MSK | Save
  • Regulation of autophagy by coordinated action of mTORC1 and protein phosphatase 2A
    Journal Article

    Wong, P. M.; Feng, Y.; Wang, J.; Shi, R.; Jiang, X.
    Nature Communications (2015)

    Fulltext@MSK | Save
  • Phase I dose escalation study of ASP8273, a mutant-selective irreversible EGFR inhibitor, in subjects with EGFR mutation positive NSCLC
    Meeting Abstract

    Yu, H. A.; Oxnard, G. R.; Spira, A. I.; Horn, L.; Weiss, J.; Feng, Y.; West, H. J.; Giaccone, G.; Evans, T. L.; Kelly, R. J.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save